Stay updated on Tildrakizumab for Chronic Plaque Psoriasis Clinical Trial

Sign up to get notified when there's something new on the Tildrakizumab for Chronic Plaque Psoriasis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tildrakizumab for Chronic Plaque Psoriasis Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.2 to v3.5.3, indicating a new page build. This change does not modify any study data, eligibility criteria, or results.
    Difference
    0.1%
    Check dated 2026-04-30T17:46:03.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    A publication citation under Study Publications was updated, changing how the same article is referenced (publication timing/formatting) from one citation variant to another.
    Difference
    0.1%
    Check dated 2026-04-23T14:46:54.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    Revision: v3.5.2 was added and Revision: v3.5.0 was removed.
    Difference
    0.1%
    Check dated 2026-04-16T10:44:24.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    45 days ago
    Change Detected
    Summary
    Added a new publication citation to the Publications section (Dermatol Ther, 2026 Mar 16) and updated the page revision to v3.5.0 (from v3.4.3).
    Difference
    0.1%
    Check dated 2026-03-18T18:03:15.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Revision: v3.4.3 implemented, replacing v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T14:45:01.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The page layout and sections appear reorganized in the new screenshot. No core study details, eligibility criteria, outcomes, or results have been added or removed.
    Difference
    0.1%
    Check dated 2026-03-04T10:43:12.000Z thumbnail image

Stay in the know with updates to Tildrakizumab for Chronic Plaque Psoriasis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tildrakizumab for Chronic Plaque Psoriasis Clinical Trial page.